Immorna Biotherapeutics, Inc.
Immorna Biotherapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine | DNA Virus Infections, Disease Attributes, Herpesviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Varicella Zoster Virus Infection, herpes zoster, infectious disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-04-23 | NCT06581575 | |
| A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, infectious disease | Active, not recruiting | Phase 1 | 2026-04-23 | NCT06564194 | |
| One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors | Malignant Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-24 | NCT06781125 |